Prelude Fertility Revenue and Competitors

Location

$200M

Total Funding

Estimated Revenue & Valuation

  • Prelude Fertility's estimated annual revenue is currently $7.8M per year.(i)
  • Prelude Fertility's estimated revenue per employee is $205,200
  • Prelude Fertility's total funding is $200M.

Employee Data

  • Prelude Fertility has 38 Employees.(i)
  • Prelude Fertility grew their employee count by 6% last year.

Prelude Fertility's People

NameTitleEmail/Phone
1
Director Revenue CycleReveal Email/Phone
2
Staff AccountantReveal Email/Phone
3
Administrative CoordinatorReveal Email/Phone
4
Cryopreservation CoordinatorReveal Email/Phone
5
Senior Team Lead: Patient Financial ServicesReveal Email/Phone
6
Payment ProcessorReveal Email/Phone
7
Chairman and FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.4M1836%N/AN/A
#2
$18M74-4%N/AN/A
#3
$162.7M48239%N/AN/A
#4
$42.8M1448%N/AN/A
#5
$26.5M984%N/AN/A
#6
$33.2M123-2%N/AN/A
#7
$29.7M11012%N/AN/A
#8
$15.5M66-21%$29.7MN/A
#9
$1645.8M435413%N/AN/A
#10
$43.7M14718%N/AN/A
Add Company

What Is Prelude Fertility?

Prelude, a comprehensive fertility company focused on providing proactive fertility care to improve people's chances of having healthy babies when they're ready. With more people delaying childbirth until their 30s and 40s to complete their education, pursue careers, or find the right partner, Prelude aims to give people more reproductive choices and control over their biological clocks using The Prelude Method. The Prelude Method is a four-step process that includes egg and sperm freezing, genetic testing, embryo creation, and single embryo transfer. Currently, around 18% of women never get to have a baby and another 20% have just one baby when they wanted more. By coupling earlier decision-making with the latest reproductive science and technology, The Prelude Method can dramatically increase the probability of having a healthy baby and decrease the chances of requiring infertility therapy later in life.

keywords:N/A

$200M

Total Funding

38

Number of Employees

$7.8M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Prelude Fertility News

2022-04-20 - Global Human Oocyte Cryopreservation Market 2022-2028 by ...

Prelude Fertility. The following key nations are included in the market research: North America (United States, Canada and Mexico); Europe (...

2022-04-17 - AI-trained embryo labeling technique boosts IVF success

... Medical Center and Ben-Gurion University in Beersheva, Tel Aviv University and New York University Langone Prelude Fertility Center.

2022-04-06 - Comprehensive Study Finds Fairtility's AI-Trained Embryo ...

McCulloh from New York University Langone Prelude Fertility Center, Dr. Or from Kaplan Medical Center OB/GYN Fertility and IVF Unit, and Dr.

2021-04-19 - Nation's Largest Provider of Fertility Services Launches Awareness Campaign in Conjunction with National Infertility Awareness Week

HOUSTON, April 19, 2021 /PRNewswire/ -- The Prelude Network (Prelude), the largest network of fertility clinics in the United States, announces today the launch of "Infertility is More than Meets the Eye," an integrated campaign designed to bring attention to the complicated and often complex ...

2019-09-06 - 2027 IVF Services Market Sourcing Strategy with Future ...

2027 IVF Services Market Sourcing Strategy with Future Insights Led by BIOART Fertility Clinic, Prelude Fertility, Gift ov life, Create Health, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M380%N/A
#2
$7.4M380%N/A
#3
$7.6M38-14%N/A
#4
$6.2M38-39%N/A
#5
$3.5M389%N/A

Prelude Fertility Funding

DateAmountRoundLead InvestorsReference
2016-10-21$200.0MUndisclosedArticle
2017-10-31$2919633Article